🇺🇸 FDA
Patent

US 11912998

Method of treating aging-associated cognitive impairment by reducing CCR3

granted A61KA61K2039/505A61K31/00

Quick answer

US patent 11912998 (Method of treating aging-associated cognitive impairment by reducing CCR3) held by United States Government as represented by the Department of Veterans Affairs expires Mon Feb 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States Government as represented by the Department of Veterans Affairs
Grant date
Tue Feb 27 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K2039/505, A61K31/00, A61K31/7088, A61K38/19